SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-14-003951
Filing Date
2014-08-13
Accepted
2014-08-13 16:17:50
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081314.htm 10-Q 1644459
2 EXHIBIT 31.1 exh_311.htm EX-31.1 11474
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11780
4 EXHIBIT 32.1 exh_321.htm EX-32.1 7468
5 EXHIBIT 32.2 exh_322.htm EX-32.1 7499
  Complete submission text file 0001171843-14-003951.txt   10351446

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amph-20140630.xml EX-101.INS 1870855
7 XBRL TAXONOMY EXTENSION SCHEMA amph-20140630.xsd EX-101.SCH 75750
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amph-20140630_cal.xml EX-101.CAL 46507
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amph-20140630_def.xml EX-101.DEF 336393
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE amph-20140630_lab.xml EX-101.LAB 549253
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amph-20140630_pre.xml EX-101.PRE 337321
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 141037734
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences